These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1973916

  • 1. [Chronic heart failure: improvement of the prognosis by therapy?].
    Drexler H.
    Herz; 1990 Jun; 15(3):214-21. PubMed ID: 1973916
    [Abstract] [Full Text] [Related]

  • 2. [Drug therapy of heart failure].
    Follath F.
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F, Perkan A, Sinagra G, Di Lenarda A, Pinamonti B, Zecchin M.
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [Abstract] [Full Text] [Related]

  • 6. Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials.
    Francis GS.
    Circulation; 1987 May; 75(5 Pt 2):IV74-9. PubMed ID: 3568319
    [Abstract] [Full Text] [Related]

  • 7. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R, Kunstmann S, Jalil J.
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A review of heart failure treatment.
    Guyatt GH, Devereaux PJ.
    Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical aspects of differential drug therapy of chronic heart failure].
    Erdmann E, Beuckelmann D, Böhm M, Schwinger HG.
    Z Kardiol; 1992 Jan; 81 Suppl 4():97-103. PubMed ID: 1290310
    [Abstract] [Full Text] [Related]

  • 14. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P, Buser P, Osswald S, Pfisterer M.
    Schweiz Med Wochenschr; 1996 May 25; 126(21):933-45. PubMed ID: 8693314
    [Abstract] [Full Text] [Related]

  • 15. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F.
    Praxis (Bern 1994); 1997 Feb 11; 86(7):254-7. PubMed ID: 9139344
    [Abstract] [Full Text] [Related]

  • 16. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P, Paci MV, Rappelli A.
    Ann Ital Med Int; 1994 Oct 11; 9 Suppl():16S-18S. PubMed ID: 7857751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Vasodilator therapy in cardiac failure].
    Akatsuka N.
    Nihon Rinsho; 1993 May 11; 51(5):1276-80. PubMed ID: 8101237
    [Abstract] [Full Text] [Related]

  • 19. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
    Cohn JN.
    Herz; 1991 Sep 11; 16 Spec No 1():267-71. PubMed ID: 1820292
    [Abstract] [Full Text] [Related]

  • 20. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y.
    J Cardiol; 1996 Aug 11; 28(2):99-112. PubMed ID: 8814528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.